Top Industry Leaders in the Mendelian Disorders Testing Market
Latest Mendelian Disorders Testing Companies Updates:
Illumina: Launched the TruSight One Expanded Carrier Screening panel, covering over 500 conditions, including numerous Mendelian disorders.
Invitae: Secured FDA approval for its Myriad Foresight carrier screening test, expanding their offerings in prenatal and preconception testing.
Sophia Genetics: Partnered with Illumina to develop and commercialize AI-powered solutions for analyzing whole-genome sequencing data in Mendelian disorders.
Fulgent Genetics: Announced the launch of its Gene Finder test, enabling comprehensive analysis of rare genetic variants for personalized diagnosis and treatment.
List of Mendelian Disorders Testing Key companies in the market:
- Celera Group (U.S.)
- Abbott Laboratories (U.S.)
- ELITechGroup (France)
- Quest Diagnostics (U.S.)
- AutoGenomics (U.S.)
- PerkinElmer Inc. (U.S.)
- Roche Diagnostics (Switzerland)
- Bio-Rad Laboratories, Inc. (U.S.)
- Applied Biosystems Inc. (U.S.)